Szymanska, S.; Markiewicz-Kijewska, M.; Pyzlak, M.; Karkucinska-Wienckowska, A.; Ciopinski, M.; Czubkowski, P.; Kaliciński, P.
Tissue Expression of Programmed Cell Death 1 Ligand1 (PD-L1) in Biopsies of Transplant Livers of Pediatric Patients as a Possible Marker of Acute Cellular Rejection. J. Clin. Med. 2023, 12, 4269.
https://doi.org/10.3390/jcm12134269
AMA Style
Szymanska S, Markiewicz-Kijewska M, Pyzlak M, Karkucinska-Wienckowska A, Ciopinski M, Czubkowski P, Kaliciński P.
Tissue Expression of Programmed Cell Death 1 Ligand1 (PD-L1) in Biopsies of Transplant Livers of Pediatric Patients as a Possible Marker of Acute Cellular Rejection. Journal of Clinical Medicine. 2023; 12(13):4269.
https://doi.org/10.3390/jcm12134269
Chicago/Turabian Style
Szymanska, Sylwia, Malgorzata Markiewicz-Kijewska, Michal Pyzlak, Agnieszka Karkucinska-Wienckowska, Mateusz Ciopinski, Piotr Czubkowski, and Piotr Kaliciński.
2023. "Tissue Expression of Programmed Cell Death 1 Ligand1 (PD-L1) in Biopsies of Transplant Livers of Pediatric Patients as a Possible Marker of Acute Cellular Rejection" Journal of Clinical Medicine 12, no. 13: 4269.
https://doi.org/10.3390/jcm12134269
APA Style
Szymanska, S., Markiewicz-Kijewska, M., Pyzlak, M., Karkucinska-Wienckowska, A., Ciopinski, M., Czubkowski, P., & Kaliciński, P.
(2023). Tissue Expression of Programmed Cell Death 1 Ligand1 (PD-L1) in Biopsies of Transplant Livers of Pediatric Patients as a Possible Marker of Acute Cellular Rejection. Journal of Clinical Medicine, 12(13), 4269.
https://doi.org/10.3390/jcm12134269
